Starbucks: Analysts Expect Q4 Earnings of $0.99 Per Share

Starbucks (NASDAQ: SBUX) will be reporting its fourth quarter financial results today after the markets close. Analysts have a consensus $129.25 12-month price target on the company, via a total of 37 analysts, with 12 analysts having strong buy ratings. 10 analysts meanwhile have buy ratings, 14 analysts have a hold rating and a single analyst has a sell rating on the company. The street high comes from Kalinowski Equity Research with a $148 price target, and the lowest target sits at $95.

26 analysts have revenue estimates for the fourth quarter. The mean revenue estimate between all 26 analysts is $8.21 billion; this number has been revised upwards from $8.07 billion at the start of April. The highest revenue estimate is $8.45 billion, while the lowest is $7.92 billion.

Onto EBITDA estimates, there are currently 18 analysts who have fourth-quarter EBITDA estimates. The mean is currently $1.93 billion, with this number having been revised upwards from $1.9 billion at the start of April. The street high estimate currently sits at $2.05 billion in EBITDA and the lowest is $1.85 billion.

Analysts estimate that quarterly earnings per share will come in at $0.99, with this number being revised upwards from $0.96 at the start of April. Street high is $1.05 and the lowest estimate is $10.93 per share for the quarter.


Information for this briefing was found via Edgar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why Copper Is Heading To $30 And Silver To $200 | Craig Parry

Mako Mining Q3 Earnings: The Transitional Quarter

B2Gold Q3 Earnings: Goose Troubles Cloud The Narrative

Recommended

Emerita Resources Awards Contract For Pre-Feasibility Study On Iberian Belt West Project

Selkirk Copper Appoints Two Members Of Selkirk First Nation To Leadership Team

Related News

Teladoc: Mixed Results From Analysts Following Q4 Results

On February 24th, Teladoc Health (NYSE: TDOC) reported their full-year and fourth quarter results. Fourth...

Friday, February 26, 2021, 04:06:40 PM

Jushi: Canaccord Reiterates Price Target Following Financials Finally Being Released

Earlier this week, Jushi Holdings Inc. (CSE: JUSH) finally reported their first quarter 2021 and...

Saturday, June 12, 2021, 04:19:00 PM

Harvest Health: Canaccord Reiterates Price Target Following Earnings

On August 10, Harvest Health and Recreation (CSE: HARV) reported its second quarter results. The...

Thursday, August 12, 2021, 03:49:00 PM

Uranium Royalty: Canaccord Gives Price Target A Lift After Physical Purchases

On September 15th, Uranium Royalty Corp. (TSXV: URC) announced that they purchased an additional 300,000...

Monday, September 20, 2021, 11:36:00 AM

Cognetivity Neurosciences: Echelon Initiates Coverage With $0.85 Price Target

On Friday, Echelon Capital Markets initiated coverage on Cognetivity Neurosciences (CSE: CGN) with a speculative...

Monday, April 19, 2021, 10:36:00 AM